Premium
Airway reflux
Author(s) -
Johnston Nikki,
Ondrey Frank,
Rosen Rachel,
Hurley Bryan P.,
Gould Jon,
Allen Jacquie,
DelGaudio John,
Altman Kenneth W.
Publication year - 2016
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/nyas.13080
Subject(s) - pepsin , airway , reflux , medicine , intensive care medicine , gastroenterology , chemistry , disease , surgery , biochemistry , enzyme
An ever‐increasing number of adult and pediatric disorders have been shown to be influenced or caused by airway reflux. This has become a controversial and complicated aspect of medicine that requires a multidisciplinary approach. Evidence indicates that it is not only the acidic components of gastric refluxate that injure extraesophageal tissues but also the nonacidic components, such as pepsin and bile. There is a realization that proton pump inhibitors will not be effective when nonacidic components of refluxate are causing the problem. New in vitro and in vivo models for the study of airway reflux and new therapeutic and surgical approaches are discussed in this review article.